Back to top
more

CryoLife, Inc. (CRY)

(Delayed Data from NYSE)

$31.42 USD

31.42
264,840

-0.08 (-0.25%)

Updated May 3, 2019 04:02 PM ET

After-Market: $31.42 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Artivion, Inc. [CRY]

Reports for Purchase

Showing records 1 - 20 ( 35 total )

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 1

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for CRY

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 2

09/03/2020

Daily Note

Pages: 11

EUROPE MORNING SUMMARY

Provider: Oppenheimer & Co. Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 3

09/03/2020

Daily Note

Pages: 13

MORNING RESEARCH SUMMARY

Provider: Oppenheimer & Co. Inc.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 4

09/02/2020

Company Report

Pages: 5

Ascyrus Medical Acquisition Continues Trend of Bolton Products

Provider: Oppenheimer & Co. Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 5

07/02/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 6

07/02/2013

Company Report

Pages: 4

We are dropping coverage due to the realignment of the Med Tech research team.

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 7

05/01/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 8

04/30/2013

Company Report

Pages: 8

Good Start - Consistent Outlook; Maintain Neutral

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 9

04/17/2013

Daily Note

Pages: 8

1Q13 MedTech Preview: ALGN ICUI TRIB CRY CPTS ATEC RTIX SLTM VOLC ATRC (Part 1)

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 10

04/03/2013

Industry Report

Pages: 9

Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 11

02/15/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 12

02/14/2013

Company Report

Pages: 7

Good 4Q; Weaker FY13 EPS Outlook Due to R&D Investment; Maintain Neutral

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 13

02/01/2013

Daily Note

Pages: 7

Healthcare- 4Q12 Med Tech Earnings Preview

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 14

01/14/2013

Industry Report

Pages: 8

Healthcare -4Q 2012: Quarterly Medical Technology Trading & Acquisition Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 15

10/31/2012

Daily Note

Pages: 26

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 75.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 16

10/31/2012

Company Report

Pages: 7

3Q - Raising PT on Beat and Raise; Guidance Still Conservative; Neutral

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 17

10/15/2012

Daily Note

Pages: 6

Healthcare: 3Q12 Medical Tech Earnings Preview

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 18

08/01/2012

Daily Note

Pages: 26

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 75.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 19

07/31/2012

Company Report

Pages: 7

Revs On-Track; Normalized EPS Guidance Down Modestly; Neutral

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Artivion, Inc.

Industry: Medical - Instruments

Record: 20

07/06/2012

Industry Report

Pages: 8

Healthcare - 2Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party
// eof